PBG BioPharma Inc. Announces the launch of a Phase 2/3 Clinical Trial on its Cannabinoid-based Drug Product ProZ-001 as an Adjunctive Therapy for Acute Bipolar Depression
PBG BioPharma Inc. Successfully Files Cannabinoid Master Drug File to Health Canada
PBG BioPharma achieves Food Safety System Certification (FSSC 22000)
PBG BioPharma Inc. Announces Launch of GenBioChem® Line of Natural Health Products
PBG BioPharma Inc. Receives Controlled Drug and Substances Dealer’s Licence
PBG BioPharma Inc. Receives Cannabis 2.0 Sales Amendment to Health Canada Licence
PBG BioPharma Inc. receives GMP Manufacturing Site Licence for NHPs
PBG announces development of plant isolate PBG-007 as a potential Broad Spectrum Anti-viral
PBG BioPharma Inc. donates nearly 1 million hand sanitizer bottles to Canadian communities
PBG Biopharma Received its Cannabis Analytical Testing License from Health Canada
PBG BioPharma announces the Official Completion of their Manufacturing and Research Laboratories
GBC® Immunity is the first Canadian NHP successfully donated to first-line responders in Wuhan
PBG BioPharma announces ribbon cutting ceremony for the opening of their new building
PARTNER WITH US
Got a project?
Let’s talk.
We’re a team of scientists who are excited about unique ideas and help cannabis companies realize their product vision.
